Neurogen Corporation (NASDAQ: NRGN), a drug development company, announced today that it will release its second quarter 2009 financial results on Friday, August 14, 2009 after the closing of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 5:00 p.m. EDT to review the results.

The news release and live webcast may be accessed through the investor relations section of the Company's web site: www.neurogen.com. The webcast will also be archived in this section, under "Events Calendar and Replays."

About Neurogen

Neurogen Corporation is a drug development company focusing on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen conducts its drug development independently and, when advantageous, collaborates with world-class pharmaceutical companies to access additional resources and expertise.

Neurogen (NASDAQ:NRGN)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024 Neurogen 차트를 더 보려면 여기를 클릭.
Neurogen (NASDAQ:NRGN)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024 Neurogen 차트를 더 보려면 여기를 클릭.